Correlation Between Achilles Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and SAB Biotherapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for Achilles Therapeutics and SAB Biotherapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Achilles and SAB is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Achilles Therapeutics is expected to generate 2.44 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Achilles Therapeutics PLC is 5.09 times less risky than SAB Biotherapeutics. It trades about 0.22 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 277.00 in SAB Biotherapeutics on August 26, 2024 and sell it today you would earn a total of 36.00 from holding SAB Biotherapeutics or generate 13.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. SAB Biotherapeutics
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| SAB Biotherapeutics |
Achilles Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Achilles Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |